{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:32:34Z","timestamp":1760189554903},"reference-count":41,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2000,4,7]]},"abstract":"<jats:p> PURPOSE: To determine the frequency of and risk factors for second malignant neoplasms (SMNs) after treatment for Hodgkin\u2019s disease diagnosed in children and adolescents. <\/jats:p><jats:p> PATIENTS AND METHODS: One hundred eighty-two consecutive, previously untreated patients with Hodgkin\u2019s disease who were younger than 20 years of age at diagnosis and who were referred to Roswell Park Cancer Institute (Buffalo, NY) for treatment between January 1, 1960, and December 31, 1989, were studied. Sex-specific standardized incidence ratios (SIRs) were calculated. Kaplan-Meier survival estimates and Cox regression analyses were performed to determine the relationship of several demographic and treatment variables to SMN incidence. <\/jats:p><jats:p> RESULTS: Twenty-eight patients developed an SMN at a mean of 14.93 \u00b1 8.09 years (range, 2.65 to 29.88 years) after diagnosis of Hodgkin\u2019s disease. The cumulative percentage of patients who developed an SMN was 26.27 \u00b1 6.75% at 30 years after diagnosis. The SIR was 9.39 (95% confidence interval [CI], 4.05 to 18.49) for male patients and 10.16 (95% CI, 5.56 to 17.05) for female patients. The most frequent SMNs were thyroid cancer, breast cancer, nonmelanoma skin cancer, non-Hodgkin\u2019s lymphoma, and acute leukemia. Multivariate analysis of sex, treatment with any alkylating agent, treatment with doxorubicin, splenectomy, and relapse (as a time-dependent covariate) with time to SMN onset gave nonsignificant results. <\/jats:p><jats:p> CONCLUSION: Successfully treated children and adolescents with Hodgkin\u2019s disease have a substantial risk for the occurrence of subsequent neoplasms. The most frequent SMNs (skin, thyroid, and breast) are readily detected by physical examination and available screening procedures. <\/jats:p>","DOI":"10.1200\/jco.2000.18.7.1492","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T07:12:37Z","timestamp":1487920357000},"page":"1492-1499","source":"Crossref","is-referenced-by-count":115,"title":["Second Malignant Neoplasms After Treatment for Hodgkin\u2019s Disease in Childhood or Adolescence"],"prefix":"10.1200","volume":"18","author":[{"given":"Daniel M.","family":"Green","sequence":"first","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hyland","sequence":"additional","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice P.","family":"Barcos","sequence":"additional","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda C.","family":"Hall","sequence":"additional","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Zevon","sequence":"additional","affiliation":[{"name":"From the Departments of PediatricsCancer Prevention, Epidemiology and Biostatistics, Pathology, Radiation Medicine, and Psychology, Roswell Park Cancer Institute; Departments of Pediatrics and Social and Preventive Medicine, School of Medicine and Biomedical Sciences, and Department of Natural Sciences, Roswell Park Graduate Division, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-0187","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S"},{"key":"R3-0187","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-73-6-881"},{"key":"R4-0187","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7"},{"key":"R6-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.2.255"},{"key":"R7-0187","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.4.1209.1209"},{"key":"R8-0187","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.9.3625.bloodjournal8793625"},{"key":"R9-0187","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19881001)62:7<1364::AID-CNCR2820620721>3.0.CO;2-T"},{"key":"R10-0187","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90880-P"},{"key":"R11-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.603"},{"key":"R12-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1442"},{"key":"R13-0187","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199606)26:6<373::AID-MPO1>3.0.CO;2-E"},{"key":"R14-0187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603213341201"},{"key":"R15-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.536"},{"key":"R16-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.11.3592"},{"key":"R17-0187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608013350515"},{"key":"R18-0187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198703193161203"},{"key":"R19-0187","doi-asserted-by":"crossref","unstructured":"Pedersen-Bjergaard  J,  Specht  L,  Larsen  SO, et al:  Risk of therapy-related leukaemia and pre-leukaemia after Hodgkin\u2019s disease:  Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 11:83,1987-88,","DOI":"10.1016\/S0140-6736(87)92744-9"},{"key":"R20-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.7.1148"},{"key":"R21-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.5.925"},{"key":"R22-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3207"},{"key":"R23-0187","unstructured":"Heaston  JF,  Kelly  JAB,  Meigs  JW, et al:  Forty-five years of cancer incidence in Connecticut:  1935-79. Natl Cancer Inst Monogr 70:1,1986-706,"},{"key":"R27-0187","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"R29-0187","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.1.25"},{"key":"R31-0187","doi-asserted-by":"publisher","DOI":"10.2307\/3578591"},{"key":"R32-0187","doi-asserted-by":"publisher","DOI":"10.2307\/3579003"},{"key":"R33-0187","unstructured":"Tucker  MA,  Morris-Jones  PH,  Boice  JD Jr, et al:  Therapeutic radiation at a young age is linked to secondary thyroid cancer.  Cancer Res 51:2885,1991-2888,"},{"key":"R34-0187","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970516)71:4<510::AID-IJC2>3.0.CO;2-X"},{"key":"R35-0187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220102"},{"key":"R36-0187","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90490-G"},{"key":"R37-0187","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6832.951"},{"key":"R38-0187","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950220102"},{"key":"R39-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.8.1851"},{"key":"R40-0187","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197506)35:6<1678::AID-CNCR2820350629>3.0.CO;2-K"},{"key":"R41-0187","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(79)90810-1"},{"key":"R42-0187","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<946::AID-CNCR2820360316>3.0.CO;2-5"},{"key":"R43-0187","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198709033171002"},{"key":"R44-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.338"},{"key":"R45-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1674"},{"key":"R46-0187","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00235-9"},{"key":"R47-0187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.11.1662"},{"key":"R48-0187","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70318-2"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2000.18.7.1492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:39:29Z","timestamp":1653514769000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2000.18.7.1492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,4,7]]}},"alternative-id":["10.1200\/JCO.2000.18.7.1492"],"URL":"https:\/\/doi.org\/10.1200\/jco.2000.18.7.1492","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,7]]}}}